Cargando…

Coexistence of EZH2, NOTCH1, IL7R, and PHF6 Mutations in Adult T-cell Acute Lymphoblastic Leukemia

Detalles Bibliográficos
Autores principales:	Zhou, Xilian, Gu, Yan, Han, Qi, Soliman, Mario, Song, Chunhua, Ge, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774360/ https://www.ncbi.nlm.nih.gov/pubmed/28747286 http://dx.doi.org/10.4274/tjh.2017.0194

Ejemplares similares

Co-existence of PHF6 and NOTCH1 mutations in adult T-cell acute lymphoblastic leukemia
por: LI, MIN, et al.
Publicado: (2016)

PHF6 mutations in T-cell acute lymphoblastic leukemia
por: Van Vlierberghe, Pieter, et al.
Publicado: (2010)

PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression
por: Yuan, Shengnan, et al.
Publicado: (2021)

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
por: Shochat, Chen, et al.
Publicado: (2011)

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
por: Shochat, Chen, et al.
Publicado: (2011)

Mutations increased overexpression of Notch1 in T-cell acute lymphoblastic leukemia
por: Lin, Chunlan, et al.
Publicado: (2012)

Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia
por: Ge, Zheng, et al.
Publicado: (2016)

USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia
por: Shan, Huizhuang, et al.
Publicado: (2018)

Antitumoral effects of cannabis in Notch1‐mutated T‐cell acute lymphoblastic leukemia
por: Besser, Elazar, et al.
Publicado: (2023)

IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update
por: Oliveira, Mariana L., et al.
Publicado: (2019)

Meta-analysis of the clinical characteristics and prognostic relevance of NOTCH1 and FBXW7 mutation in T-cell acute lymphoblastic leukemia
por: Liu, Rong-Bin, et al.
Publicado: (2017)

A Case of Acute Eosinophilic Leukemia with a Novel PHF6 Mutation
por: Lipof, J. J., et al.
Publicado: (2021)

PHF6 Mutations in Hematologic Malignancies
por: Kurzer, Jason H., et al.
Publicado: (2021)

Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia
por: Oliveira, Mariana L., et al.
Publicado: (2022)

Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction
por: Ge, Zheng, et al.
Publicado: (2016)

Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations
por: Senkevitch, Emilee, et al.
Publicado: (2018)

Characterization of activating mutations of NOTCH3 in T cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies
por: Bernasconi-Elias, Paula, et al.
Publicado: (2016)

NOTCH1 pathway activating mutations and clonal evolution in pediatric T‐cell acute lymphoblastic leukemia
por: Kimura, Shunsuke, et al.
Publicado: (2019)

Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression
por: Tsaouli, Georgia, et al.
Publicado: (2019)

NOTCH1-driven UBR7 stimulates nucleotide biosynthesis to promote T cell acute lymphoblastic leukemia
por: Srivastava, Shashank, et al.
Publicado: (2021)

The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia
por: Choi, Sung Hee, et al.
Publicado: (2017)

Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia
por: Guo, Xing, et al.
Publicado: (2015)

IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study
por: Li, Yunlei, et al.
Publicado: (2016)

Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma
por: Silva, Ana, et al.
Publicado: (2021)

The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T- cell acute lymphoblastic leukemia: A report from the Children's Oncology Group
por: Gedman, Amanda Larson, et al.
Publicado: (2009)

NOTCH-ing up nucleotide metabolism in T-cell acute lymphoblastic leukemia
por: Volk, Andrew
Publicado: (2021)

Targeting EZH2 Promotes Chemosensitivity of BCL-2 Inhibitor through Suppressing PI3K and c-KIT Signaling in Acute Myeloid Leukemia
por: Yang, Chan, et al.
Publicado: (2022)

A Regulatory Loop Involving Notch and Wnt Signaling Maintains Leukemia Stem Cells in T-Cell Acute Lymphoblastic Leukemia
por: Zhang, Ling, et al.
Publicado: (2021)

TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells
por: Riz, Irene, et al.
Publicado: (2010)

Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms
por: Zhang, Qi, et al.
Publicado: (2019)

T-lymphoid/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with NOTCH1 mutation as a good prognostic factor
por: Noronha, Elda Pereira, et al.
Publicado: (2019)

Epigenetic Inactivation of Notch-Hes Pathway in Human B-Cell Acute Lymphoblastic Leukemia
por: Kuang, Shao-Qing, et al.
Publicado: (2013)

Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in acute lymphoblastic leukemia
por: Herranz, Daniel, et al.
Publicado: (2015)

Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia
por: Zheng, Ruyue, et al.
Publicado: (2020)

RUNX1 colludes with NOTCH1 to reprogram chromatin in T cell acute lymphoblastic leukemia
por: Islam, Rashedul, et al.
Publicado: (2023)

Resistance mechanism to Notch inhibition and combination therapy in human T-cell acute lymphoblastic leukemia
por: Cao, Linlin, et al.
Publicado: (2023)

EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches
por: D’Angelo, V., et al.
Publicado: (2015)

Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia
por: Danis, Etienne, et al.
Publicado: (2016)

P339: DEVELOPMENT OF ANTI-IL-7RΑ ANTIBODIES AS A TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Duque, Mafalda, et al.
Publicado: (2023)

PHF6 mutation is associated with poor outcome in acute myeloid leukaemia
por: Huang, Kexiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m8h19gd9ebf5va3t36uttbn0ot